MSH6 and asthma: In addition, the KEGG pathways enriched in the MSH6 low expression group were involved in multiple immune-related diseases, such as inflammatory bowel disease and asthma, and were also related to T cell differentiation and natural killer cell-mediated cytotoxicity (Figure 5C).